(Q36809161)

16 August 2017

1 reference

title

Osteoporosis and periodontal disease (English)

1 reference

16 August 2017

Nico C Geurs

1

1 reference

16 August 2017

language of work or name

1 reference

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

44

1 reference

16 August 2017

page(s)

29-43

1 reference

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of testosterone and estradiol in a man with aromatase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Exercise in the prevention of falls in older people: a systematic literature review examining the rationale and the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Calcium intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bone biomarkers as tools in osteoporosis management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Current state of bone densitometry for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Osteoporosis and periodontal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Intravenous bisphosphonates and osteonecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

World-wide projections for hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The importance of calcium intake for lifelong skeletal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Post-menopausal bone loss and its relationship to oral bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Estimation of skeletal bone mineral density by means of the trabecular pattern of the alveolar bone, its interdental thickness, and the bone mass of the mandible.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Long-term risk of osteoporotic fracture in Malmö.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Smoking and fracture risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of starting age of physical activity on bone mass in the dominant arm of tennis and squash players.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Hip fractures in Finland between 1970 and 1997 and predictions for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Use of hormone replacement therapy by postmenopausal women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The effect of smoking at different life stages on bone mineral density in elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Relationships between mandibular and skeletal bone in an osteoporotic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17 beta and dydrogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bones, genes and fractures: workshop on the genetics of osteoporosis: from basic to clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bone response to termination of oestrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

One year outcomes and costs following a vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Prevalence of low femoral bone density in older U.S. adults from NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Fracture protection provided by long-term estrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

21 January 2018

Epidemiology worldwide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bone density and fracture risk in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Cross-sectional versus longitudinal evaluation of bone loss in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

An investigation of the relationship between systemic bone density and clinical periodontal status in post-menopausal Asian-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Endogenous factors affecting bone mineral content in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Clinical practice. Screening for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Direct clinical and welfare costs of osteoporotic fractures in elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Radial cortical and trabecular bone densities of men and women standardized with the European Forearm Phantom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Exercise for osteoporosis--is walking enough? The case for site specificity and resistive exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Avascular necrosis of the jaws: risk factors in metastatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Young Finns Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The role of osteopenia in oral bone loss and periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Osteonecrosis of the jaws associated with cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

A meta-analysis of the effects of cigarette smoking on bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

The epidemiology of osteoporosis and fractures in geriatric medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Osteoporosis: a risk factor in periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Smoking Eliminates the Protective Effect of Oral Estrogens on the Risk for Hip Fracture among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

Walking and Leisure-Time Activity and Risk of Hip Fracture in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2006.00194.X

10.1111/J.1600-0757.2006.00194.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference